INS and type 2 diabetes mellitus: Conversely, the D2R agonist bromocriptine, which has been used for over 40 years to treat Parkinson’s disease and hyperprolactinemia (6), was found to lower blood glucose levels and improve insulin sensitivity in patients with T2DM (7).